phenylalanine and fedratinib

phenylalanine has been researched along with fedratinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cullen, DE; Doukas, J; Gilliland, DG; Gozo, M; Hood, JD; Kharas, MG; Ko, YD; Lee, BH; Leeman, DS; Levine, RL; Mak, CC; Martin, M; McDowell, EP; Moore, SA; Noronha, G; Okabe, R; Soll, RM; Tefferi, A; Wernig, G	1

Other Studies

1 other study(ies) available for phenylalanine and fedratinib

Article	Year
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera. Cancer cell, 2008, Volume: 13, Issue:4 Topics: Amino Acid Substitution; Animals; Bone Marrow Transplantation; Cell Line, Tumor; Colony-Forming Units Assay; Disease Models, Animal; Endpoint Determination; Flow Cytometry; Hematopoietic System; Humans; Janus Kinase 2; Mice; Mice, Inbred C57BL; Phenylalanine; Polycythemia Vera; Protein Kinase Inhibitors; Pyrrolidines; Signal Transduction; Sulfonamides; Survival Rate; Treatment Outcome; Valine	2008

Article

Year

Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.

Cancer cell, 2008, Volume: 13, Issue:4

Topics: Amino Acid Substitution; Animals; Bone Marrow Transplantation; Cell Line, Tumor; Colony-Forming Units Assay; Disease Models, Animal; Endpoint Determination; Flow Cytometry; Hematopoietic System; Humans; Janus Kinase 2; Mice; Mice, Inbred C57BL; Phenylalanine; Polycythemia Vera; Protein Kinase Inhibitors; Pyrrolidines; Signal Transduction; Sulfonamides; Survival Rate; Treatment Outcome; Valine

2008